Cytokeratin Fragment 21-1 Measurement

Known as: Cytokeratin 19 Fragment, CYFRA211, Cytokeratin Fragment 21-1 
The determination of the amount of the cytokeratin 19 fragment 21-1 present in a sample.
National Institutes of Health

Related topics

Related topics

3 relations
CDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by NameClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Increased Red Blood Cell Distribution Width Associates with Cancer Stage and Prognosis in Patients with Lung Cancer
BACKGROUND Red cell distribution width (RDW), one of many routinely examined parameters, shows the heterogeneity in erythrocyte… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer.
PURPOSE Bcl-2 is a critical regulator of apoptosis that is overexpressed in the majority of small cell lung cancers (SCLC… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
2011
2011
Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary site
Cancer may be diagnosed in advanced stages, when the patient has already developed metastasis, with symptoms that can be also… (More)
  • table 1
  • table 2
  • table 5
  • table 6
  • table 7
Is this relevant?
2009
2009
Clinical significance and prognostic value of serum Dickkopf-1 concentrations in patients with lung cancer.
BACKGROUND Dickkopf-1 (DKK1), a secreted protein, is known as a negative regulator of the Wnt signaling pathway, which has been… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2007
2007
Serum Cytokeratin 19 Fragment (CYFRA21-1) as a Prognostic Factor in Intrahepatic Cholangiocarcinoma
A high serum cytokeratin 19 fragment (CYFRA21-1) concentration in patients with various cancers is associated with poor prognosis… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2006
2006
Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer.
BACKGROUND The authors assessed the predictive and prognostic role of decline in the serum levels of carcinoembryonic antigen… (More)
Is this relevant?
2006
2006
Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer.
Autoantibodies against tumor antigens represent one type of biomarker that may be assayed in serum for detection of cancer and… (More)
Is this relevant?
2004
2004
CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients.
Currently, no further therapy in addition to surgery is recommended in completely resected NSCLC stage I patients. However, the 5… (More)
Is this relevant?
2003
2003
Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.
BACKGROUND We previously reported that positron emission tomography (PET) with 18-F-fluorodeoxyglucose (FDG) might be a useful… (More)
Is this relevant?
2003
2003
Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma.
High preoperative serum midkine concentration is associated with poor survival in patients with esophageal cancer, even after… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?